NRCME Endocrine and Metabolic Conditions 4 — Questions and Answers
Question 1: A CMV driver with type 2 diabetes uses insulin glargine (basal insulin only) with no history of hypoglycemia and stable A1c of 7.1%. Under FMCSA standards, what is the most appropriate certification action?
- Disqualify permanently due to insulin use
- Certify for 1 year with annual endocrinologist evaluation
- Certify for 2 years with no additional requirements
- Require exemption through the Federal Diabetes Exemption Program (Correct answer)
Correct answer: Require exemption through the Federal Diabetes Exemption Program
Commercial drivers using any insulin require a Federal Diabetes Exemption to operate CMVs in interstate commerce under FMCSA regulations.
Question 2: Which metabolic condition is most commonly associated with obstructive sleep apnea in commercial drivers, creating a dual disqualifying concern for the NRCME examiner?
- Hypothyroidism
- Obesity with metabolic syndrome (Correct answer)
- Type 1 diabetes
- Addison's disease
Correct answer: Obesity with metabolic syndrome
Obesity with metabolic syndrome is strongly associated with OSA, and both conditions independently affect driver safety and certification.
Question 3: A driver reports taking levothyroxine for hypothyroidism. TSH is 2.1 mIU/L and the driver is asymptomatic. What is the correct NRCME certification decision?
- Disqualify; thyroid disorders are disqualifying
- Certify; well-controlled hypothyroidism on replacement therapy is not disqualifying (Correct answer)
- Certify only after cardiology clearance
- Require a 3-month waiting period after starting levothyroxine
Correct answer: Certify; well-controlled hypothyroidism on replacement therapy is not disqualifying
Well-controlled hypothyroidism with normal TSH on stable replacement therapy does not impair driving and is not a disqualifying condition.
Question 4: During a DOT physical, a driver's random blood glucose is 310 mg/dL. The driver denies any diabetes diagnosis. What is the examiner's best next step?
- Certify immediately; random glucose is not diagnostic
- Disqualify permanently for uncontrolled diabetes
- Defer certification and refer the driver for evaluation and diagnosis (Correct answer)
- Issue a 90-day certificate pending A1c results
Correct answer: Defer certification and refer the driver for evaluation and diagnosis
A markedly elevated random glucose warrants deferral and referral for proper diagnosis before certification can be granted.
Question 5: A driver with Cushing's syndrome has been treated with surgical resection and is now in remission for 18 months with normal cortisol levels. Which concern is MOST relevant for the NRCME examiner assessing current fitness for duty?
- Residual hypertension and diabetes that may have developed during active disease (Correct answer)
- Permanent disqualification due to the history of Cushing's syndrome
- Mandatory exemption program enrollment
- Required psychiatric evaluation for mood disorders
Correct answer: Residual hypertension and diabetes that may have developed during active disease
Cushing's syndrome can cause lasting hypertension and diabetes even after remission, and these must be evaluated for their impact on driver safety.
Question 6: An NRCME examiner is evaluating a driver with a BMI of 41 who is otherwise healthy. Blood pressure is 124/78 mmHg, fasting glucose is 98 mg/dL. What should the examiner document regarding obesity?
- Permanently disqualify; BMI over 40 is disqualifying under FMCSA rules
- Certify with no restrictions; obesity alone is not a disqualifying condition (Correct answer)
- Certify only after a sleep study rules out OSA
- Issue a 1-year certificate contingent on weight loss
Correct answer: Certify with no restrictions; obesity alone is not a disqualifying condition
Obesity alone without associated disqualifying conditions (e.g., uncontrolled hypertension, diabetes, OSA) does not disqualify a CMV driver under current FMCSA standards.
Question 7: A driver with hyperparathyroidism presents with serum calcium of 11.8 mg/dL and complaints of fatigue and difficulty concentrating. What is the most appropriate NRCME action?
- Certify for 2 years; calcium of 11.8 is borderline
- Certify for 1 year with repeat labs
- Disqualify until hypercalcemia is treated and symptoms resolve (Correct answer)
- Refer to nephrology only
Correct answer: Disqualify until hypercalcemia is treated and symptoms resolve
Symptomatic hypercalcemia causes cognitive impairment and fatigue that directly compromise driving safety, warranting disqualification until treated.
NRCME Endocrine and Metabolic Conditions 4
A CMV driver with type 2 diabetes uses insulin glargine (basal insulin only) with no history of hypoglycemia and stable A1c of 7.1%.
Under FMCSA standards, what is the most appropriate certification action?